Updated: May 9, 2026

Cooper C. Collins

TXMDTherapeuticsMD, Inc.SEC CIK: 0001485508
Estimated Net Worth
$20.7 Million
Last Updated: May 9, 2026 08:59 PM EST

Transaction Summary

Total Transactions41
Buy-Sell Ratio0.67
Buy Transactions8
Sell Transactions12

Transaction Volume

Total Volume-$20.12M
Net Volume$23.52M
Buy Volume$1.70M
Sell Volume-$21.82M

Trade Analysis

AVG Trade Size-$614.02K
Largest Trade$725.00K
Most Active MonthMar
Most Active Year2013

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Cooper C. Collins has an estimated net worth of $20.7 Million. This is based on reported shares across multiple companies, which include TherapeuticsMD, Inc., and PERNIX THERAPEUTICS HOLDINGS, INC..



2021 was Cooper C. Collins's most active year for acquiring shares with 5 total transactions. Cooper C. Collins's most active month to acquire stocks was the month of May. 2013 was Cooper C. Collins's most active year for disposing of shares, totalling 15 transactions. Cooper C. Collins's most active month to dispose stocks was the month of September. 2021 saw Cooper C. Collins paying a total of $1,303,500.00 for 2,196,038 shares, this is the most they've acquired in one year. In 2014 Cooper C. Collins cashed out on 3,860,000 shares for a total of $13,103,902.88, their largest year based on trade value.

Holdings & Transactions

TXMDtherapeuticsmd, inc.
Updated: Nov 05, 2025VIEW QUOTE
Form TypeSEC Filing
8.50K8.50KNov 03View
60.52KFeb 18View
0.094.09K$1.73$7.10K52.02KAug 22View
0.031.20K$1.70$2.04K47.92KAug 21View
8.50K8.50KJul 17View
5.00K5.00KSep 29View
46.72KAug 18View
0.811.00M$0.58$578.50K2.24MNov 18View
4.221.00M$0.73$725.00K1.24MAug 17 - 18View
236.86KAug 10View
99.17K99.17KJul 01View
96.86K96.86KJun 18View
1.1274.00K$1.45$107.30K140.00KJun 08 - 09View
75.00K75.00KJun 20View
0.8330.00K$3.33$99.87K66.00KMay 13View
50.00K50.00KJul 02View
50.00K50.00KJun 21View
25.00K25.00KDec 21View
0.8016.00K$6.23$99.72K36.00KMar 11View
50.00K50.00KDec 17View
100.00K100.00KMar 25View
20.00K$3.84$76.89K20.00KJun 05View
0.4770.00K220.00KJan 06View
-1.002.63M$1.75-$4.61MJun 14View
1.0075.00K150.00KMay 01View
75.00K75.00KApr 16View
2.63MView
pernix therapeutics holdings, inc.
Chief Strategic Officer Officer
Updated: Apr 02, 2014
Form TypeSEC Filing
-0.0390.00K$5.26-$473.08K3.53MScheduledApr 01 - 02View
-0.583.59M$3.40-$12.22M3.62MScheduledMar 03 - 04View
-0.0190.00K$2.22-$199.72K7.21MScheduledFeb 03 - 05View
-0.0027.96K$2.20-$61.61K7.30MScheduledJan 07View
-0.0162.04K$2.35-$145.71K7.32MScheduledJan 02 - 06View
-0.0137.45K$2.31-$86.63K7.39MScheduledDec 05 - 06View
-0.0152.55K$2.44-$128.21K7.42MScheduledDec 02 - 04View
-0.0190.00K$2.01-$180.61K7.48MScheduledNov 01 - 05View
-0.0023.36K$2.47-$57.73K7.57MScheduledOct 04 - 08View
-0.0166.64K$2.55-$169.74K7.59MScheduledOct 01 - 03View
-0.161.25M$4.04-$5.05M7.66MJul 24View
-0.05498.43K$7.00-$3.49M8.91MJul 21View
9.40M9.41MMar 09View
View